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Abstract Gab proteins, including mammalian Gab1, Gab2,
Gab3, Drosophila DOS and Caenorhabditis elegans Soc1,
comprise a growing family of scaffolding/docking molecules
involved in multiple signaling pathways mediated by receptor
tyrosine kinases (RTKs) and non-RTK receptors. This paper
reviews the structure/function relationships of Gab proteins and
their biological roles during normal growth, differentiation and
development programs. ß 2002 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
The gab genes, encoding mammalian Gab1, Gab2, Gab3,
the Drosophila homolog DOS (Daughter Of Sevenless), and
the Caenorhabditis elegans homolog Soc1 (Suppressor-Of
Clear), de¢ne a family of sca¡olding proteins closely related
to insulin receptor substrates (IRS-1, IRS-2, IRS-3), ¢broblast
growth factor substrate (FRS2), linker of T cell (LAT) and
downstream of kinase (Dok) (reviewed in [1^4]). They are so
called sca¡olding or docking proteins because of the presence
of multiple functional motifs mediating interactions with oth-
er signaling molecules. Since the cloning of DOS and Gab1 in
1996, genetic and biochemical approaches have revealed a new
family of genes involved in signaling events triggered by a
variety of stimuli, including growth factors, cytokines, and
T and B cell antigens. These studies also greatly enhanced
our knowledge of the mechanisms by which growth factor
and cytokine receptors transmit signals to downstream e¡ec-
tors that ultimately regulate cell growth and di¡erentiation.
This review will focus on the structure/function relationships
of Gab family proteins and their biological roles in growth
and di¡erentiation pathways.
2. A family of proteins participating in multiple signaling
pathways
Gab1 (Grb2-associated binder 1), the ¢rst of three mamma-
lian gab genes cloned to date, was originally isolated as a
Grb2-binding protein from a human glial tumor expression
library and found to be tyrosine phosphorylated in response
to epidermal growth factor (EGF) and insulin stimulations [5].
It was also identi¢ed independently as a Met-receptor inter-
acting protein in a yeast two-hybrid screen and as the major
tyrosine phosphorylated protein in cells transformed by the
Tpr-Met oncogene [6,7]. Further studies demonstrated that
Gab1 is also involved in a number of other signaling events
mediated by the receptors of molecules such as interleukins
(ILs), interferons (IFNs), erythropoietin (EPO), and thrombo-
poietin (TPO) (see Table 1).
Although the cDNA for gab2 gene was cloned a few years
later [8^10], a p97 or a p100 phosphoprotein associated with
the protein tyrosine phosphatase SHP2 and the p85 subunit of
phosphatidylinositol 3-kinase (PI3K) after IL3 or macrophage
colony-stimulating factor (M-CSF) stimulation was recog-
nized earlier [11,12]. This p97 or p100 protein later proved
to be the gab2 gene product [8,13]. The cloning of gab3
cDNA, on the other hand, was achieved with the aid of a
large sequencing project, and isolated based on sequence sim-
ilarities to Gab1 [14]. Further biochemical and functional
studies suggest that Gab3, like its relatives Gab1 and Gab2,
is involved in several growth factor and cytokine signaling
pathways (see Table 1).
While multiple Gab family members are found in mamma-
lian genomes, DOS is the only identi¢ed homolog in Droso-
phila. DOS was cloned as a potential substrate of the protein
tyrosine phosphatase Corkscrew (CSW, Drosophila homolog
of mammalian SHP2) and a suppressor of a constitutively
activated Sevenless receptor tyrosine kinase [15,16]. DOS is
also required for signaling by other receptor tyrosine kinases
(RTKs) such as Torso and DER (Drosophila homolog of
mammalian EGF receptor), and is essential for normal devel-
opment throughout the £y [15^18].
Recently, a DOS-like protein involved in ¢broblast growth
factor (FGF) signaling was found in C. elegans [19]. Soc1,
identi¢ed via mutations that suppress the Clear phenotype
resulting from a gain-of-function allele of let-60 ras, appar-
ently is the C. elegans homolog of mammalian gab genes.
Structure functional analyses of Soc1 indicate that this protein
is also essential for development in the nematode, and acts
together with PTP2 (C. elegans homolog of mammalian
SHP2) to mediate a portion of the EGL-15 (C. elegans homo-
log of mammalian FGF receptor) signaling cascade [19].
3. Functional motifs mediating interactions with other
signaling molecules
All Gab family proteins share a common architecture con-
sisting of a highly conserved N-terminal Pleckstrin homology
(PH) domain, a central proline-rich domain (PRD) and multi-
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ple tyrosines within potential binding motifs favored by var-
ious Src homology 2 (SH2) domain-containing proteins (Fig.
1). Mutagenesis and in vitro/in vivo binding assays have iden-
ti¢ed a number of molecules that interact with Gab family
proteins. Functional analyses in various cell systems have re-
vealed that these interactions are involved in numerous signal
transduction pathways.
3.1. PH domain
The PH domain is the most conserved structural element
among Gab family members. Several recent studies have
shown that PH domains can recognize membrane compo-
nents, most notably phosphoinositides, and therefore contrib-
ute to the membrane targeting of the protein (reviewed in
[20]). Indeed, the PH domain of Gab1 binds speci¢cally to
phosphatidylinositol 3,4,5-triphosphate (PIP3), a product of
PI3K [21^23]. Furthermore, the PH domain of Gab1 was
shown to be required for subcellular localization of the pro-
tein to the areas of cell^cell contact [22]. Mutants of Gab1
with a deletion of the entire PH domain, or point mutations
(W26A/C, R29A/C) at a conserved phospholipid-binding site,
were unable to induce Met-dependent branching tubulogene-
sis in Madin^Darby canine kidney (MDCK) cells [22,24].
These results indicate that the PH domain of Gab1 is respon-
sible for its membrane localization and its function in Met
signaling as well. Consistent with ¢ndings in mammalian sys-
tems, PH domain mutants of Drosophila DOS fail to function
in Sevenless signaling and to rescue the lethal phenotype of
DOS loss-of-function mutant £ies [17]. Similarly, a PH do-
main mutant of C. elegans Soc1 (W124A) is non-functional
[19]. These data suggest that the function of Gab PH domains
is conserved from nematodes to mammals. Interestingly, the
PH domain of DOS can be replaced by the PH domain of
Gab1, but not by a heterologous membrane anchor, a strategy
used to activate Raf by localizing it to the membrane [17,18],
suggesting that the PH domain might have additional roles in
regulating intracellular signaling rather than acting simply as
a localization module.
3.2. PRD
The central region of Gab proteins is rich in prolines and
contains numerous PXXP motifs, signatures of the binding
sites for Src homology 3 (SH3) domain-containing molecules
[25]. In fact, all Gab proteins have been found to constitu-
tively associate with the SH3 domain-containing protein Grb2
[5,8,14]. The binding sites for Grb2 have been mapped on
Gab1: a canonical Grb2-binding site with PXXPXR motif
and an atypical Grb2-binding site with a PX3RX2KP motif
[26^28]. Both sites are conserved among all Gab members, as
well as several other signaling proteins such as Slp76 and Sos
[26^28].
The Met-binding site (MBS) of Gab1, a fragment respon-
sible for the binding of phosphorylated Met receptor, is
located within the PRD too (see Fig. 1). Using yeast two-
hybrid analysis, it was found that 13 amino acids
(GMQVPPPAHMGFR) within the initially identi¢ed Gab1
Met-binding domain account for direct association with Met
receptor and this region is distinct from the Grb2-binding sites
[26]. Interestingly, Gab1 appears to speci¢cally bind to the
Met receptor, but does not associate directly with a large
number of other receptor tyrosine kinases tested (for example,
EGF receptor) [6,27]. On the other hand, Gab2 and Gab3
lack an analogous MBS in their sequences and do no exhibit
direct association with Met or other receptors. Therefore, how
is Gab1 recruited to receptors other than Met? Also, what is
the mechanism by which Gab2 and Gab3 are recruited? The
most likely answer is that Gab proteins are recruited to the
receptor complexes via an indirect mechanism. The Grb2
adapter protein is one of the candidates to mediate such an
indirect mechanism. Grb2 associates with Gab proteins con-
stitutively via its SH3 domains, and binds inducibly to speci¢c
phosphotyrosine(s) motifs in a number of receptor tyrosine
Table 1
Mammalian Gab proteins participate in multiple signaling pathways
Receptor Ligand Cell type Gab protein
phosphorylated?
Reference
Gab1 Gab2 Gab3
RTK EGF receptor EGF A431 yes yes ? [5]
Flt3 Flt3L BaF3 ? yes yes [14]
Fms M-CSF Bac1.2F5, FDFms ? yes yes [8,11]
insulin receptor insulin A431, HepG2 yes ? ? [5,58]
Kit SCF MO7E, FDFms yes yes ? [9,11]
Met HGF MDCK, A549 yes ? ? [56,57]
PDGF receptor PDGF NIH3T3 yes ? ? [9]
TrkA NGF PC12 yes ? ? [39]
Non-RTK B cell receptor anti-IgM or F(abP)2 Ramos, WEHI-231 yes yes ? [8,9,59]
EPO receptor EPO HCD57, UT7 yes yes ? [60]
G-CSF receptor G-CSF BAF-B03 ? yes ? [9]
GM-CSF receptor GM-CSF UT-7 ? yes ? [11,60]
gp130 IL-6 HepG2 yes ? ? [61]
IFN-K receptor IFN-K Hep3B yes ? ? [61]
IFN-Q receptor IFN-Q Hep3B yes ? ? [61]
IL-15 receptor IL-15 T cell, NK3.3 ? yes ? [62]
IL-2 receptor IL-2 Kit225, KT-3 ? yes ? [8,9]
IL-3 receptor IL-3 TF-1, BaF3 yes yes yes [8,9,14,61]
Mpl TPO TF-1, UT-7, MK yes yes ? [9,60,64]
prolactin R prolactin HC11 ? yes ? [63]
T cell receptor anti-CD3 Jurkat ? yes ? [8,9]
The references listed are representative, but not exclusive.
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kinases, such as EGF receptor, Met receptor and Fms recep-
tor. Therefore, Grb2 could carry its associated Gab proteins
to the activated receptor complexes upon ligand stimulation.
This hypothesis is supported by the fact that the association
between Gab1 and EGF receptor is abolished by mutations
either at the Grb2-binding site of Gab1 or that of EGF re-
ceptor [21^23,27]. Moreover, Gab1 fails to be tyrosine phos-
phorylated in response to EGF in ¢broblasts isolated from
mice expressing a null mutant of Grb2 [29], providing genetic
evidence that Gab1 is recruited to EGF receptor through a
Grb2-dependent mechanism. Interestingly, in IL2 and IL3 re-
ceptor signaling, the common L-chain of the receptors does
not contain a binding site for Grb2, but does contain a bind-
ing site for SHC. Gab2 was found to be recruited to the
receptor through a Gab2^Grb2^SHC pathway [30], a mecha-
nism that is also Grb2-dependent but requires a fourth protein
to achieve this goal. Apparently, in addition to Grb2, it is
likely that other related proteins with SH2 and SH3 domains
also might be capable of ful¢lling such an adapter function.
Obviously, the direct and indirect mechanisms are not mu-
tually exclusive. Gab1 can be recruited to Met receptor via
both direct and indirect means, but to EGF receptor only
through an indirect mechanism presumably. Would the di¡er-
ence in Gab1 recruitment account for the di¡erent biological
activities of Met receptor versus EGF receptor? An interesting
observation in the epithelial cell line MDCK is that stimu-
lation with hepatocyte growth factor (HGF) induces pro-
longed tyrosine phosphorylation of Gab1 (s 60 min) and
promotes branching morphogenesis of the cells, whereas
EGF stimulation only results in transient phosphorylation
of Gab1 (15 min), and is unable to induce a morphogenic
program [22]. Furthermore, the prolonged Gab1 phosphory-
lation in response to HGF also correlates with sustained acti-
vation of MAPK and Akt activities [31,32]. Although the key
regulator responsible for these di¡erences remains elusive, it is
certainly worthwhile to investigate further the mechanism by
which Gab proteins are recruited to various receptors and
how these associations a¡ect the downstream signaling events.
3.3. Multiple phosphotyrosines
Upon stimulation, Gab proteins undergo rapid tyrosine
phosphorylation, creating a number of docking sites to medi-
ate interactions with SH2 domain-containing proteins such as
the tyrosine phosphatase SHP2 and the p85 subunit of PI3K.
Association with these molecules was found to be critical for
the function of Gab proteins in mediating intracellular signal-
ing pathways from the receptors.
3.3.1. Gab^SHP2 interaction. One or two tyrosines lo-
cated in the most C-terminal ends of the Gab family proteins
fall within consensus binding motifs (YXXV/I/L) for SHP2,
upon tyrosine phosphorylation (see Fig. 1). Indeed, all mam-
malian Gab proteins, as well as the Drosophila DOS and C.
elegans Soc1, have been shown to bind SHP2 (or its homo-
logs) [8,14,16,19,33^35], indicating that recruitment of SHP2
is a conserved feature that gab family genes retained from C.
elegans to mammalian systems.
The functional signi¢cance of the Gab^SHP2 interaction
has been extensively studied using mutants of Gab family
proteins unable to bind SHP2 or to its homologs. Mutant
DOS bearing a Y to F mutation at either of the two CSW-
binding sites is unable to function during Sevenless signaling
and fails to rescue the lethality associated with dos loss-of-
function mutations [17,36]. The Gab1 mutant unable to
bind SHP2 is defective in delivering a signal for Met-depen-
dent morphogenesis and blocks MAPK activation by EGF
and lysophosphatidic acid [26,34,35,37]; the Gab2 mutant un-
able to bind SHP2 blocked IL3-induced c-fos promoter acti-
vation and M-CSF-induced macrophage di¡erentiation [8,13].
Similarly, mutant Soc1 unable to bind PTP2 fails to function
in EGL15 signaling [19]. Moreover, mutations at tyrosines
other than the SHP2-binding sites of DOS and Soc1 have
no e¡ect on the function of DOS or Soc1 [19,36]. These
Fig. 1. Gab family proteins. Schematic domain structures of three mammalian Gab proteins (represented by mouse Gab1, 2 and 3), Drosophila
DOS and C. elegans Soc1 are shown. All Gab family proteins consist of a N-terminal PH domain, a central PRD and multiple tyrosines (Y)
within potential binding motifs favored by various SH2 domain-containing proteins (as indicated in the ¢gure). The binding site for Grb2 and
Met receptor is also indicated.
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data underscore the importance of Gab^SHP2 interaction and
strongly suggest that the primary role of Gab proteins is to
recruit SHP2 phosphatase.
How could the Gab^SHP2 interaction lead to activation of
downstream signaling? Accumulated evidence indicates that
Gab proteins can function to activate SHP2 phosphatase,
which in turn activates MAPK signaling [8,13,26,34,35,37].
It was found recently that Y627 and Y659 of human Gab1
constitute a bisphosphoryl tyrosine-based activation motif
that binds and activates SHP2 phosphatase [35]. In addition,
a mutant DOS or Soc1 containing all tyrosines changed to
phenylalanines, except the tyrosine(s) for SHP2-binding, is
su⁄cient to mediate RTK signaling and to rescue the devel-
opmental lethality resulting from the loss-of-function muta-
tions [19,36]. These results provide strong evidence that Gab
proteins are physiological activators of SHP2 phosphatase.
Association between the phosphotyrosine(s) of Gab proteins
and the SH2 domains of SHP2 is an essential part of the
mechanism that upregulates the phosphatase activity of
SHP2, leading to activation of the MAPK cascade and sub-
sequent biological responses.
A key question following this hypothesis is what the sub-
strate(s) and downstream e¡ector(s) are for SHP2 phospha-
tase. Gab2 and DOS were originally identi¢ed as the sub-
strates of SHP2 since they were hyperphosphorylated in the
cells expressing the substrate-trapping mutant of SHP2 (a cat-
alytically inactive SHP2 mutant) [12,15]. In vitro phosphatase
assays further supported that Gab proteins are substrates of
SHP2 [9,12,35], although there is no evidence to date that
links dephosphorylation of any phosphotyrosines on Gab
proteins to the positive role of SHP2. Interestingly, it was
found that an N-SH2 domain deletion mutant of SHP2,
which is constitutively active but unable to bind Gab1, failed
to rescue the defect of an SHP2-binding mutant of Gab1 in
MAPK activation, whereas expression of a chimera with fu-
sion of these two mutant proteins induced constitutive activa-
tion of MAPK activity [35]. These results suggest that physical
association of Gab1 and SHP2 not only activates SHP2 phos-
phatase, but may also allow SHP2 to access its substrates.
Such a substrate(s), if not Gab itself, would be present,
most likely, in the complex of Gab^SHP2 proteins. One po-
tential candidate that falls into this category is a p90 protein,
which associates with Gab1 and is hyperphosphorylated in
cells expressing an N-SH2 domain deletion mutant of SHP2
[38]. However, the identity of this p90 protein is currently
unknown. Apparently, it remains a challenging job to identify
the real substrate/e¡ector(s) of SHP2, but this next step is
crucial for understanding the mechanism by which SHP2 ac-
tivates downstream signaling.
3.3.2. Gab^p85 interaction. Another well-de¢ned binding
partner of Gab proteins is the p85-subunit of PI3K. Three
YXXM motifs (consensus binding site for the SH2 domain
of p85) are present in all mammalian Gab proteins but only
one such site was found in DOS or Soc1 (see Fig. 1). While
the mutant of Drosophila DOS or C. elegans Soc1 ablating
this site does not exhibit functional abnormalities [17,36], mu-
tations at the p85-binding sites of mammalian Gab1 and
Gab2 resulted in incapacitation of several signaling systems
[30,39^41]. It has been shown that physical association be-
tween p85 and Gab1 or Gab2 is crucial in mediating the
PI3K/Akt signaling pathway induced by a variety of stimuli
[21,22,30,39^44]. Overexpression of Gab1 potentiates FGF-in-
duced Akt activity, whereas overexpression of the p85-binding
mutant of Gab1 results in decreased Akt activation [42]. Such
a mutant is also unable to provide anti-apoptotic signals in
response to nerve growth factor (NGF) stimulation [39]. Sim-
ilarly, mutations at the p85-binding sites of Gab2 were found
to impair the ability of IL-3 to activate Akt and to induce cell
growth [30]. These results suggest that while the Gab^SHP2
interaction is important for MAP kinase activation, the Gab^
p85 interaction plays a key role in activating the PI3 kinase/
Akt pathway in mammalian cells. Moreover, since the activa-
tion of PI3K leads to the production of PIP3, which in turn
can bind to the PH domain of Gab proteins and presumably
promote further activation of PI3 kinases, a positive feedback
loop could be formed to amplify the signals through the Gab
proteins [21]. Such a positive feedback mechanism could be
important for generating a speci¢c biological response in cer-
tain signaling pathways.
3.3.3. Other interactions. In addition to the binding sites
for SHP2 and p85, both Gab1 and Gab2 contain numerous
YXXP motifs, potential binding sites for the SH2 domain of
PLCQ or Crk family proteins [45]. Binding of Gab1 to Crk,
CrkL and PLCQ have been reported [26,32,46^48]. Interest-
ingly, it has been found that Gab1 associates with Crk in
response to Met activation and this association correlates
with anchorage-independent growth and JNK (c-Jun N-termi-
nal kinase) activation in cells transformed by the Met receptor
oncoprotein [46,47]. On the other hand, Gab2 has been found
to interact with CrkL in yeast two-hybrid system and also in
human T lymphocytes in response to IL2 [49,50], although the
functional signi¢cance of the Gab2^CrkL association has not
yet been addressed. Notably, potential Crk-binding sites are
completely absent in Gab3 protein, implying a possible mo-
lecular mechanism for the functional di¡erences among these
family members.
4. Developmental requirement of mammalian Gabs
The presence of multiple gab genes in the mammalian ge-
nome suggests that the function of each Gab protein may be
specialized or restricted in certain signaling pathways or tis-
sues. Alternatively, these gene products may have functional
redundancy and therefore the ability to compensate for de-
fects of other co-expressed Gab proteins. By Northern blot
and RT-PCR analyses, the expression patterns of the three
mammalian gab genes have been extensively studied
[5,6,8,14]. Gab1 appears to exhibit the most widespread ex-
pression and abundance. It is found in all tissues examined,
including brain, heart, liver, lung kidney pancreas, spleen,
thymus and uterus of the adult mouse, and expressed at an
earlier stage (ES cell) during development [14]. Gab2 expres-
sion is relatively weak in most tissue samples as compared
with Gab1. However, it is prominently expressed in a number
of hematopoietic progenitor cell lines, such as BAF3, FDC-P1
[5,6,8,14]. The expression pattern of Gab3 is also restricted to
the hematopoietic system [5,6,8,14]; it is expressed in spleen,
thymus, and a number of hematopoietic cell lines, but very
low in solid tissue samples. These results indicate that the
three mammalian Gab genes have unique but overlapping
expression patterns.
Consistent with early and widespread expression during de-
velopment, a targeted disruption in Gab1 is embryonic lethal
in mice [51,52]. These mice die between E13.5 and E18.5 and
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display developmental defects in the heart, placenta and skin.
Furthermore, Gab13=3 ¢broblasts have markedly reduced
MAPK activity in response to IL-6, EGF or PDGF stimu-
lation [51], suggesting a role for Gab1 in mediating MAPK
activity via multiple growth factor receptors.
Among Gab family members, Gab1 is unique in its ability
to directly associate with the phosphorylated Met receptor.
Interestingly, Gab1-de¢cient mice have a phenotype reminis-
cent of those mice harboring mutations in the HGF and c-
Met genes. These mice die at similar embryonic stage as the
Gab13=3 animals, due to a severe de¢cit in development of
the placenta; they all display a reduced liver size and have
defects in the migration of muscle precursor cells [52^55].
These results provide genetic evidence that Gab1 is essential
for HGF-Met signaling, and Gab2 and/or Gab3 are unable to
compensate for the function of Gab1 in vivo.
Mice with targeted disruption of the gab2 gene have also
been generated. Gab2 protein is quite abundant in hemato-
poietic cells and the functional importance of Gab2 in IL2,
IL3 and M-CSF signaling pathways has been well established
in tissue culture systems [8,13]. Intriguingly, no apparent de-
fects in the development of hematopoietic lineages were ob-
served in Gab2 knock-out mice [44]. These mice develop nor-
mally and are generally healthy. However, closer examination
demonstrates that these mice have impaired allergic reactions.
IgE receptor signaling is defective in bone marrow-derived
mast cells from Gab2 3=3 mice, due mainly to the inability
to induce PI3K activation in these cells. Clearly, Gab2 has at
least some distinct functions from Gab1 in vivo.
The lack of an apparent developmental phenotype of Gab2-
de¢cient mice has raised a number of questions. First, are the
Gab2 knock-out mice generated really Gab2 null mice?
Although Gab2 targeting vector was constructed to delete
the ¢rst exon of Gab2, presumably eliminating the gene prod-
uct of gab2, a truncated protein, possibly arising from a cryp-
tic promoter in the ¢rst intron of the Gab2 gene, was found in
Gab2 3=3 cells [44], suggesting that this truncated protein may
partially compensate for full length Gab2. Second, could com-
pensation by other Gab family members account for the lack
of phenotype in the Gab2 knock-out animals? Since Gab1 is
more abundant than Gab2 in most tissues and Gab3 is co-
expressed with Gab2 in most hematopoietic cells, it is possible
that the loss of Gab2 function can be compensated by other
Gab proteins. Moreover, the genome sequence project has
uncovered more Gab members in the mammalian genomes
(unpublished observations). Therefore, continued e¡orts will
be required to elucidate the in vivo function of each Gab
member, and understand their individual roles in growth
and di¡erentiation signaling.
5. Concluding remarks
In vitro and in vivo studies of Gab family proteins during
the last few years have revealed a novel mechanism that links
RTK and non-TK receptors to several downstream signaling
pathways. As shown in the proposed model (Fig. 2), Gab
proteins, recruited to the activated receptor complexes by di-
rect and/or indirect means, are phosphorylated by receptor
tyrosine kinases (or receptor-associated tyrosine kinases for
non-RTK receptors), and subsequently activate MAP kinase,
PI3 kinase and JNK pathways via direct association with
SHP2, p85 and Crk family proteins. The signals activated
through Gab proteins and signals activated via Gab-indepen-
dent pathways may merge to generate speci¢c biological re-
sponses that are crucial for the normal growth, di¡erentiation
and development programs.
One central, enduring question regarding the signaling of
receptor tyrosine kinases is : how is the speci¢city of each
receptor tyrosine kinase generated? The discovery of Gab
family genes provides new clues toward generating such spec-
i¢city. First, di¡erent receptors might adopt di¡erent ways to
recruit Gab proteins. Depending on the a⁄nity between the
receptor and Gab protein, di¡erent signaling kinetics could be
generated, which could result in di¡erent biological responses.
This is exempli¢ed by the studies of Gab1 recruitment mech-
anisms and the di¡erent cellular responses to HGF and EGF
Fig. 2. A model of RTK signaling via Gab-dependent and -indepen-
dent pathways. Gab proteins, recruited to the activated receptor
complexes by direct and/or indirect means, are phosphorylated by
receptor tyrosine kinases (or receptor-associated tyrosine kinases for
non-RTK receptors). Phosphorylated Gab proteins bind to SHP2,
p85 and Crk family proteins and induce subsequent activation of
MAPK, PI3K and JNK pathway respectively. The total MAPK ac-
tivities could result from the activation via a Gab^SHP2^? (an un-
known protein) pathway (yellow arrow), or a Gab-independent clas-
sical Grb2^SOS^RAS pathway (blue arrows), or the blend of both
(green arrow), depending on the receptor and the cell context. Simi-
larly, the total PI3K activities could be contributed by the activa-
tion via Gab^p85 interaction (yellow arrow) or via direct association
between the receptor and p85 (red arrow), or both (orange). The
combination of the signals from both Gab-dependent and -indepen-
dent pathways contribute to speci¢c biological responses, which are
crucial for the normal growth, di¡erentiation and development pro-
grams.
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in MDCK cells [22,27,31,32]. Secondly, integration of signals
generated by Gab protein and other activators could result in
speci¢c biological e¡ects. Many receptors, such as Fms, di-
rectly associate with Grb2, p85, and other signaling molecules.
While these proteins can facilitate the recruitment of Gab
protein and result in subsequent activation of signaling events
through Gab, they can also transmit signals independently.
For example, binding of Grb2 to an activated receptor will
trigger MAPK activation via a Grb2^SOS^RAS pathway.
Although Gab proteins bind to Grb2 directly, mutational
analyses in both Soc1 and DOS have shown that the
MAPK activation from Gab proteins requires their associa-
tions with SHP2, but not Grb2 [17,36]. Therefore, signals via
Gab^SHP2 and Grb2^SOS^RAS pathways could join togeth-
er to activate MAPK pathway and result in speci¢c biological
response due to the additive or synergistic e¡ects. A similar
scenario may apply to Gab-dependent and -independent acti-
vation of PI3K and JNK pathways. Finally, the presence of
three or more Gab members in mammalian cells provides
further complexity and presumably speci¢city for RTK or
non-RTK signaling. Although the functional di¡erences
among the three members remain ambiguous so far, there is
clearly a structural basis for their disparities. Gab1 contains a
unique MBS, which has been shown to be critical for Gab1-
mediated branching morphogenesis in Met receptor signaling.
On the other hand, Gab3 does not contain any potential Crk/
CrkL-binding site, implicating its inability to mediate Crk-de-
pendent JNK activation. Moreover, in a physiological cell
context, a variety of receptors and more than one Gab protein
might be co-expressed or expressed in a certain order, evi-
denced by the induction of Gab3 protein after activation of
Fms receptor and Gab2 in FD-Fms cells [14]. Therefore, si-
multaneous or sequential activation of the receptors and Gab
proteins could lead to qualitatively and quantitatively di¡er-
ent signal output, which confers speci¢c messages in the con-
trol of cell growth and di¡erentiation during the development
of multicellular organisms. These new molecular insights are
but one fabulous gift we have received from the Gabs.
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